Letrozole: A Trusted Therapy for Hormone-Dependent Breast Cancer

daisymiller

Letrozole is an aromatase inhibitor widely used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, thereby slowing or stopping the growth of estrogen-dependent tumors. Letrozole is often prescribed after surgery or radiation therapy to prevent cancer recurrence and is also used in fertility treatments under specific conditions. Its effectiveness and manageable side-effect profile make it a preferred choice in long-term cancer management.

As global demand for this essential drug grows, a reliable Letrozole exporter plays a vital role in delivering high-quality formulations to international markets. Ensuring timely access to Letrozole can make a significant difference in patient outcomes across various healthcare systems.